title: Glutathione S-transferase A4 is a positive marker for rat hepatic foci induced by clofibrate and genotoxic carcinogens.
abstract: Peroxisome proliferators (PP), including clofibrate (CF), are non-genotoxic rodent carcinogens, and oxidative DNA damages are suggested as a causative event for carcinogenesis. Gene expression profiles differ between hepatic lesions induced by PP and genotoxic carcinogens. Our previous study revealed that expression of L-bifunctional enzyme (enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase, BE) was repressed in preneoplastic lesions induced by PP, whereas it was enhanced in the surrounding tissues. In the present study, we immunohistochemically examined expression of the specific glutathione S-transferase (GST) form, GST-A4, which detoxifies 4-hydroxy-alkenal, the end-product of lipid peroxides, and nuclear factor-erythroid 2-related factor 2 (Nrf2), a transcription factor for many genes encoding drug-metabolizing enzymes and defending enzymes against oxidative stress, during rat hepatocarcinogenesis induced by CF and genotoxic carcinogens. GST-A4 and Nrf2 were not expressed in BE-negative foci at 8 weeks of CF administration, but were expressed in the foci at 60 weeks. GST-A4-positive foci appeared at later stages than BE-negative foci, but its localization was coincidental with that of the latter foci. The areas of GST-A4-positive foci were larger than those of BE-negative foci without GST-A4 expression. Most GST-A4-positive foci were also positive for Nrf2. In rat livers induced by genotoxic carcinogens, GST-P-negative foci as well as GST-P-positive foci were demonstrated. GST-A4 and Nrf2 were expressed in GST-P-negative foci, whereas they were not expressed in most GST-P-positive foci. Thus, GST-A4-positive foci developed in rat livers by CF and genotoxic carcinogen administration, indicating that the enzyme is a positive marker for hepatic foci induced by these different carcinogens.
authors.affiliation: Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Shimizu
authors.forename: Yang
authors.initials: Y
authors.lastname: Fan
authors.forename: Daisuke
authors.initials: D
authors.lastname: Yamana
authors.forename: Takuya
authors.initials: T
authors.lastname: Miura
authors.forename: Naoki
authors.initials: N
authors.lastname: Nanashima
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Yamada
authors.forename: Shigeki
authors.initials: S
authors.lastname: Tsuchida
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis*; D002994:Clofibrate / Q000633:toxicity*; D051549:Glutathione S-Transferase pi / Q000032:analysis; D005982:Glutathione Transferase / Q000032:analysis*; D007150:Immunohistochemistry; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008114:Liver Neoplasms, Experimental / Q000201:enzymology* / Q000209:etiology; D051267:NF-E2-Related Factor 2 / Q000032:analysis; D011230:Precancerous Conditions / Q000201:enzymology* / Q000209:etiology; D051381:Rats
chemical_list: D014408:Biomarkers, Tumor; D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; D051549:Glutathione S-Transferase pi; D005982:Glutathione Transferase; C496558:Gstp1 protein, rat; C041116:leukotriene-C4 synthase; D002994:Clofibrate